A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The transforming genes of oncogenic retroviruses are homologous to a group of evolutionary conserved cellular onc genes. The human cellular homologue (c-abl) of the transforming sequence of Abelson murine leukaemia virus (A-MuL V) was recently shown to be located on chromosome 9. The long arm of this chromosome is involved in a specific translocation with chromosome 22, the Philadelphia translocation (Ph1), t(9; 22) (q34, q11), which occurs in patients with chronic myelocytic leukaemia (CML)3-5. Here we investigate whether the c-abl gene is included in this translocation. Using c-abl and v-abl hybridization probes on blots of somatic cell hybrids, positive hybridization is found when the 22q- (the Philadelphia chromosome), and not the 9q+ derivative of the translocation, is present in the cell hybrids. From this we conclude that in CML, c-abl sequences are translocated from chromosome 9 to chromosome 22q-. This finding is a direct demonstration of a reciprocal exchange between the two chromosomes and suggests a role for the c-abl gene in the generation of CML.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The importance of proto-oncogenes was further highlighted by discoveries that nonviral cancers frequently have genetic alterations in proto-oncogenes that activate them and drive oncogenesis—for example, mutations in H-ras or K-ras (76), gene amplification of c-myc (77), and chromosomal translocation/activation involving c-abl (78).”
From The Discovery of Reverse Transcriptase (2016) · cites this paper as [78]
Citations
Cites
ROWLEY, J. D. (1973) · Nature · doi:10.1038/243290a0 · Cited by 4,291
Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene
Parada, L. F., Tabin, C. J., Shih, C., & Weinberg, R. A. (1982) · Nature · doi:10.1038/297474a0 · Cited by 944
Der, C. J., Krontiris, T. G., & Cooper, G. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.11.3637 · Cited by 800
A physical map of the DNA regions flanking the rabbit β-globin gene
Jeffreys, A. (1977) · Cell · doi:10.1016/0092-8674(77)90119-2 · Cited by 644
Santos, E., Tronick, S. R., Aaronson, S. A., Pulciani, S., & Barbacid, M. (1982) · Nature · doi:10.1038/298343a0 · Cited by 623
Chang, E. H., Furth, M. E., Scolnick, E. M., & Lowy, D. R. (1982) · Nature · doi:10.1038/297479a0 · Cited by 587
Abelson murine leukaemia virus protein is phosphorylated in vitro to form phosphotyrosine
Witte, O. N., Dasgupta, A., & Baltimore, D. (1980) · Nature · doi:10.1038/283826a0 · Cited by 530
Goff, S. P., Gilboa, E., Witte, O. N., & Baltimore, D. (1980) · Cell · doi:10.1016/0092-8674(80)90554-1 · Cited by 470
Khan, P. M. (1971) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(71)80007-3 · Cited by 344
Chromosomal localization of human cellular homologues of two viral oncogenes
Heisterkamp, N., Groffen, J., Stephenson, J. R., Spurr, N. K., Goodfellow, P. N., Solomon, E., Carritt, B., & Bodmer, W. F. (1982) · Nature · doi:10.1038/299747a0 · Cited by 303
Self-citation
Research works printed but not linked: 2
- Heisterkamp, N., Groffen, J. & Stephenson, J. R. J. molec. appl. Genet. (in the press).
- Ferguson-Smith, M. A. & Aitken, D. A. Cytogenet. Cell Genet. 22, 49–451 (1978).
Cited by
Items 901–1,000 of 1,000
New Possibilities for Cytogenetic Analysis of Leukemic Cells
Hagemeijer, A., Adriaansen, H. J., & Bartram, C. (1986) · Springer eBooks · doi:10.1007/978-94-009-4273-8_1 · Cited by 7
Self-citationMahon, F., Pigeonnier, V., Chahine, H., Barbot, C., Jaźwiec, B., Ripoche, J., & Reiffers, J. J. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.2003017.x · Cited by 7
“The hallmark of the chronic phase of the disease is the presence of the Philadelphia (Ph) chromosome resulting from a reciprocal translocation between chromosomes 9 and 22, leading to the formation of the BCR-ABL fusion gene (De Klein et al, 1982; Groffen et al, 1984).”
BackgroundN‐ras‐like sequences on chromosomes 9, 6 and 22 with a polymorphism at the chromosome 9 locus
Middleton-Price, H. R., Spurr, N. K., Hall, A., & Malcolm, S. (1988) · Annals of Human Genetics · doi:10.1111/j.1469-1809.1988.tb01096.x · Cited by 7
Self-citation?Masked? Ph1-chromosome in chronic myelogenous leukaemia (CML)
Verma, R. S., & Dosik, H. (1985) · Annals of Hematology · doi:10.1007/bf00320068 · Cited by 7
“Recently, emphasis has been placed in understanding the disease at a molecular level [5-8] de Klein and his colleagues [9] have localized an oncogene (c-ab 1) on the long arm of chromosome 9 band q 34 and have suggested that its translocation to the Ph 1 chromosome results in CML.”
BackgroundIsolation of Not l Sites from Chromosome 22q11
ten Hoeve, J., Morris, C. M., Poustka, A., Groffen, J., & Heisterkamp, N. (1993) · Genomics · doi:10.1016/s0888-7543(05)80360-x · Cited by 7
Self-citationImmunobiology of the expanded T cells in T-cell leukemia and T-gamma lymphocytosis
Miedema, F. F., & Melief, C. J. M. (1986) · Leukemia Research · doi:10.1016/0145-2126(86)90081-0 · Cited by 7
Moore, G. E., Hedge, P., Rider, S. H., Xu, W., Hing, S., Palmer, R. W., Sheer, D., & Solomon, E. (1989) · Genomics · doi:10.1016/0888-7543(89)90294-2 · Cited by 7
Podestà, M., Piaggio, G., Sessarego, M., Pitto, A., Benvenuto, F., Vassallo, F., Fugazza, G., Carella, A. M., & Frassoni, F. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.d01-2128.x · Cited by 7
“The leukaemic cells are characterized by the bcr/abl fusion gene (de Klein et al, 1982) resulting from a translocation between chromosomes 9 and 22.”
BackgroundChen, H., Maeda, S., Takahashi, R., & Sugiyama, T. (1987) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(87)90217-2 · Cited by 7
Boehm, T. L. J. (1985) · Progress in clinical biochemistry and medicine · doi:10.1007/978-3-642-70570-0_1 · Cited by 7
Why classical cytogenetics still matters in acute myeloid leukemia
Lazarević, V., & Johansson, B. (2020) · Expert Review of Hematology · doi:10.1080/17474086.2020.1711733 · Cited by 7
“It was then shown that leukemiaassociated translocations/inversions result in rearrangements of genes located in the breakpoints, as first shown for the MYC gene in Burkitt lymphoma/leukemia with t(8;14)(q24;q32) and the ABL1 gene in chronic myeloid leukemia with t(9;22)(q34; q11) in 1982 [5,6], and that most of them…”
BackgroundBCR‐ABL1 p210 screening for chronic myeloid leukemia in patients with peripheral blood cytoses
Fenu, E. M., O’Neill, S. S., & Insuasti‐Beltran, G. (2021) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.13635 · Cited by 7
Overview of research on fusion genes in prostate cancer
Song, C., & Chen, H. (2020) · Translational Cancer Research · doi:10.21037/tcr.2020.01.34 · Cited by 6
“In the other case, the two genes fused through translocation, such as the specific “Philadelphia chromosome” BCR-ABL in chronic myelogenous leukemia (CML) (6,7).”
BackgroundZhao, M., Dai, B., Li, X., Zhang, Y., Qiao, C., Qin, Y., Zhao, L., Li, Q., Wang, S., Yang, Y., et al. (2023) · eLife · doi:10.7554/elife.88375 · Cited by 9
JAK2Inhibition: Reviewing a New Therapeutical Option in Myeloproliferative Neoplasms
Bellido, M., & Boekhorst, P. A. W. T. (2012) · Advances in Hematology · doi:10.1155/2012/535709 · Cited by 8
“Hindawi Publishing Corporation Advances in Hematology Volume 2012, Article ID 535709, 6 pages doi:10.1155/2012/535709”
InfluentialStructural and Expression Changes of Septins in Myeloid Neoplasia
Cerveira, N., Santos, J., & Teixeira, M. R. (2009) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v15.i1-2.40 · Cited by 7
“…was a reciprocal translocation between chromosomes 9 and 22 (Rowley, 1973) and, in the 1980s, the BCR-ABL chimeric gene and protein formed as a result of the t(9;22)(q34;q11) translocation was characterized and its central role in the pathogenesis of CML was established (De Klein et al., 1982).”
BackgroundDiagnosis and individual treatment of cardiovascular diseases: targeting vascular oxidative stress
Armitage, M. E., La, M., Schmidt, H. H. H. W., & Wingler, K. (2010) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.10.40 · Cited by 6
The novel fusion transcript NR5A2‐KLHL29FT is generated by an insertion at the KLHL29 locus
Sun, Z., Ke, X., Salzberg, S. L., Kim, D., Antonescu, V., Cheng, Y., Huang, B., Song, J. H., Abraham, J. M., Ibrahim, S., et al. (2017) · Cancer · doi:10.1002/cncr.30510 · Cited by 6
“Many gene fusions have been identified in leukemias, lymphomas, and sarcomas, with the BCR-ABL fusion gene observed in patients with chronic leukemia being a notable example.(5,6) In recent decades, gene fusions also have been discovered in epithelial cancers, including TMPRSS2-ERG in patients with prostate cancer and…”
BackgroundKlumb, C. E., Barbosa, T. C., de Moraes, G. N., Schramm, M., Emerenciano, M., & Maia, R. C. (2018) · Pediatric Blood & Cancer · doi:10.1002/pbc.27570 · Cited by 6
Inhibition of Soluble Epoxide Hydrolase Attenuates Bosutinib-Induced Blood Pressure Elevation
Cui, Z., Li, B., Zhang, Y., He, J., Shi, X., Wang, H., Zhao, Y., Liu, Y., Ai, D., Zhang, X., et al. (2021) · Hypertension · doi:10.1161/hypertensionaha.121.17548 · Cited by 6
Xodo, L. E., Rathinavelan, T., Quadrifoglio, F., Manzini, G., & Yathindra, N. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.01919.x · Cited by 6
“The bcr/abl gene encodes for a protein of 210 kDa involved in the transformation of lymphocytes into malignant leukemia cells [19].”
BackgroundReduced KIR2DL1 Recognition of MHC Class I Molecules Presenting Phosphorylated Peptides
Betser-Cohen, G., Katz, G., Gonen‐Gross, T., Stern‐Ginossar, N., Arnon, T. I., Achdout, H., Gazit, R., & Mandelboim, O. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.11.6762 · Cited by 8
“that is associated with all chronic myeloid leukemia cases (36),”
BackgroundTsiakalou, V., Petropoulou, M., Ioannou, P. C., Christopoulos, T. K., Kanavakis, E., Anagnostopoulos, N. I., Savvidou, I., & Traeger‐Synodinos, J. (2009) · Analytical Chemistry · doi:10.1021/ac901584a · Cited by 6
The Role of the Philadelphia Translocation in Chronic Myelocytic Leukemia
Grosveld, G. C., HERMANS, A., de Klein, A., Bootsma, D., Heisterkamp, N., & Groffen, J. (1987) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1987.tb36254.x · Cited by 6
Self-citationPrivitera, E., Mosna, G., Sala, E. M., Spiga, I., Gambaro, F., & Ghidoni, A. (1990) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(90)90166-8 · Cited by 6
Application of Log-Linear Model in Inference on Karyotypic Evolution in Chronic Myelocytic Leukemia
Hashimoto, T., Ohtaki, M., Kamada, N., Yamamoto, H., & Munaka, M. (1990) · Environmental Health Perspectives · doi:10.1289/ehp.9087135 · Cited by 6
10 Factors involved in leukaemogenesis and haemopoiesis
Elefanty, A. G., Robb, L. G., & Begley, C. G. (1997) · Baillière s Clinical Haematology · doi:10.1016/s0950-3536(97)80028-5 · Cited by 6
Al‐Achkar, W., Wafa, A., & Almedani, S. (2010) · Oncology Letters · doi:10.3892/ol_00000078 · Cited by 6
Mohamed, A. N., Ebrahim, S. A. D., Sarkar, F. H., Uberti, J. P., & Wolman, S. R. (1995) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(94)00118-u · Cited by 6
Abbondandolo, A. (1984) · Food Additives & Contaminants · doi:10.1080/02652038409385839 · Cited by 6
Olavarría, E., Parker, S. E., Craddock, C., Philpott, N., Tiniakou, M., Chase, A., Kanfer, E., Apperley, J. F., & Goldman, J. M. (2000) · PubMed · Cited by 6
Reinartz, J. J. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-125-1_3 · Cited by 7
Stanier, R. Y., Ingraham, J. L., Wheelis, M. L., & Painter, P. R. (1986) · General Microbiology · doi:10.1007/978-1-349-08754-9_31 · Cited by 6
Grignani, F., & Goldman, J. M. (1985) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(85)80019-6 · Cited by 6
Detection of mutations and DNA polymorphisms using whole genome Southern Cross hybridization
Ruvkun, G., Gilbert, W., & Horvitz, H. R. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.4.809 · Cited by 6
Ino, T., Kurosawa, Y., Yoshida, M., & Hirano, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.12.4264 · Cited by 6
Zaccaria, A., Rosti, G., Testoni, N., Santucci, M. A., Tassinari, A., Celso, B., Buzzi, M., Miggiano, M. C., & Tura, S. (1991) · Leukemia Research · doi:10.1016/0145-2126(91)90003-c · Cited by 6
Leukaemia: a genetic disorder of haemopoietic cells.
Luzzatto, L., & Pandolfi, P. P. (1993) · BMJ · doi:10.1136/bmj.307.6904.579 · Cited by 6
Chemitiganti, S., Verma, R. S., Silver, R. T., Coleman, M., & Dosik, H. (1985) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(85)90215-8 · Cited by 6
Gene activation by induced DNA rearrangements.
Schnipper, L. E., Chan, V., Sedivy, J. M., Jat, P., & Sharp, P. A. (1989) · PubMed · Cited by 6
Masked antisense: a molecular configuration for discriminating similar RNA targets
Stocks, M., & Rabbitts, T. H. (2000) · EMBO Reports · doi:10.1093/embo-reports/kvd003 · Cited by 6
Retinoblastoma: Importance of recessive mutations in tumorigenesis
Phillips, R. A., & Gallie, B. L. (1984) · Journal of Cellular Physiology · doi:10.1002/jcp.1041210410 · Cited by 6
Regional location of T cell receptor gene Ti alpha on human chromosome 14.
Barker, P. E., Royer, H., Ruddle, F. H., & Reinherz, E. L. (1985) · The Journal of Experimental Medicine · doi:10.1084/jem.162.1.387 · Cited by 6
“10, (8) 41pT2A, (9) WAV17, (10) BDA 14b25, (I1) BDA 10a3, (16) FRY 4.”
BackgroundStructures and Activities of Activated abl Oncogenes
Risser, R., & Holland, G. D. (1989) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-74697-0_4 · Cited by 6
Cytogenetics in Leukemia: Implications for Pathogenesis and Prognosis
Hossfeld, D. K., & Weh, H. J. (1984) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-82249-0_2 · Cited by 6
Cytogenetic Studies in Human Neoplasia
Gebhart, E. (1987) · Springer eBooks · doi:10.1007/978-3-642-72802-0_6 · Cited by 6
Traffic light at DSB –transit regulation between gene transcription and DNA repair
Modafferi, S., Esposito, F., Tavella, S., Gioia, U., & Francia, S. (2024) · FEBS Letters · doi:10.1002/1873-3468.15024 · Cited by 6
Analogies for Teaching Mutant Allele Dominance Concepts
Seipelt-Thiemann, R. L. (2012) · Creative Education · doi:10.4236/ce.2012.326133 · Cited by 5
Liu, H., Li, H., Feng, Z., Tai, J., Meng, Y., Wang, H., Xin, H., Zhang, S., Zuo, M., Zhang, Y., et al. (2009) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190802709438 · Cited by 5
“The fusion gene product of t(9;22), Bcr/Abl, is a constitutively active tyrosine kinase [1,2].”
BackgroundLeukemias, Lymphomas, and Other Related Disorders
Zhang, Y., & Rowley, J. D. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00079-3 · Cited by 7
Vardiman, J. W. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7216-0040-6.00046-0 · Cited by 5
Frequency of different Bcr-abl Fusion Transcripts in CML Patients in Pakistan
Irshad, S., Butt, M. A., & Joyia, A. (2012) · International Journal for Agro Veterinary and Medical Sciences · doi:10.5455/ijavms.25-1344841051 · Cited by 5
Clinical & Experimental Pathology
Ren, R., Fedoriw, Y. D., & Willis, M. S. (2012) · Cited by 5
Delihas, N. (2020) · Non-Coding RNA · doi:10.3390/ncrna6030036 · Cited by 5
“The BCR gene is important clinically as it is associated with the production of the Philadelphia chromosome in chronic myelogenous leukemia [10,11].”
BackgroundMinhajuddin, M., Winters, A. C., Ye, H., Pei, S., Stevens, B. M., Gillen, A. E., Engel, K. L., Gipson, S., Ransom, M., Amaya, M., et al. (2024) · Haematologica · doi:10.3324/haematol.2023.284716 · Cited by 8
t(1;19) and t(12;17) in childhood acute lymphoblastic leukemia of pre-B type
Ghione, F., Gargano, D., Guazzelli, C., & Lippi, A. (1988) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(88)90228-2 · Cited by 5
Novel Translocation in Acute Megakaryoblastic Leukemia (AML-M7)
Toretsky, J. A., Everly, E. M., Padilla‐Nash, H. M., Chen, A. R., Abruzzo, L. V., Eskenazi, A. E., Frantz, C., Ried, T., & Stamberg, J. (2003) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-200305000-00009 · Cited by 5
Heissig, B., Pasternak, G., Hörner, S., Schwerdtfeger, R., Rossol, S., & Hehlmann, R. (2000) · Leukemia Research · doi:10.1016/s0145-2126(99)00171-x · Cited by 5
Morgan, R., Stebbins, R. D., Hecht, F., & Sandberg, A. A. (1985) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(85)90211-0 · Cited by 5
Activation of the abl oncogene and its involvement in chromosomal translocations in human leukemia
Rosson, D., & Reddy, E. P. (1988) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/0165-1110(88)90002-4 · Cited by 5
He, Q., Dong, J., Zhen, H., Ying, Y., Zhang, J., Li, Q., Li, B., & Zhou, Y. (2010) · Leukemia Research · doi:10.1016/j.leukres.2010.11.012 · Cited by 5
Michiels, J. J. (2015) · Journal of Hematology & Thromboembolic Diseases · doi:10.4172/2329-8790.1000192 · Cited by 5
“Groffen Grosveld found that c-ABL was translocated to the Ph1chromosome and subsequently discovered the breakpoint cluster region (BCR) on chromosome 22 [4-7].”
BackgroundImmunogenicity of fusion proteins
Gambacorti-Passerini, C. B. (1993) · International Journal of Clinical & Laboratory Research · doi:10.1007/bf02592307 · Cited by 5
Inokuchi, K., Nakayama, K., Tauchi, T., Takaku, T., Yokose, N., Yamaguchi, H., Kumagai, T., Komatsu, N., & Ohyashiki, K. (2018) · Leukemia Research · doi:10.1016/j.leukres.2018.01.005 · Cited by 7
Borg, D. C. (1985) · Springer eBooks · doi:10.1007/978-1-4684-4970-9_3 · Cited by 5
ABL oncogene expression during erythroleukemia cell differentiation
Leibowitz, D. S., Popenoe, D., Mears, J. G., Bank, A., & Schaefer-Rego, K. (1991) · Leukemia Research · doi:10.1016/0145-2126(91)90146-k · Cited by 5
The Molecular Biology of Leukemias
Gelb, A. B., & Medeiros, L. J. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-125-1_19 · Cited by 5
Druker, B. J. (2005) · Wiley eBooks · doi:10.1002/9780470987063.ch7 · Cited by 5
Diagnostic value of Bcr sequences
Bartram, C. R., Arnold, R., & Kubanek, B. (1986) · Leukemia Research · doi:10.1016/0145-2126(86)90275-4 · Cited by 5
Self-citationJuvenile chronic myeloid leukemia: No rearrangement of the breakpoint cluster region
Nakamura, H., Sadamori, N., Ichimaru, M., Shigeno, K., Kinoshita, K.-I., Ohyashiki, J. H., & Toyama, K. (1988) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(88)90152-5 · Cited by 5
London, B., Pinkerton, P. H., & Senn, J. S. (1986) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(86)90102-0 · Cited by 5
Verma, R. S., Thomas, S., Coleman, M., & Silver, R. T. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910410609 · Cited by 5
Restoration of nonclonal hematopoiesis in chronic myelogenous leukemia with interferon alpha
Egert, G., Kanz, L., Löhr, G. W., & Fauser, A. (1990) · Annals of Hematology · doi:10.1007/bf01736229 · Cited by 5
“Cytogenetic studies, glucose-6-phosphate dehydrogenase (G6PD) isoenzyme analysis, and, recently, analysis of the expression of the abl oncogene in cells from CML patients have demonstrated that CML is a clonal disorder of the pluripotent hematopoietic stem cells [6, 13, 14].”
BackgroundTharapel, S. A., Vnencak‐Jones, C. L., Whitlock, J. A., & Jain, R. (1992) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870040412 · Cited by 5
Analysis of gene expression during hematopoiesis: Present and future applications
Takeshita, K., Benz, E. J. J., & Bank, A. (1985) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(85)80020-2 · Cited by 5
The variable hematologic expression of the BCR-ABL genomic mutation and its possible determinants
Fitzgerald, P. H., & Morris, C. M. (1989) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(89)90003-4 · Cited by 5
Genetic change in the cancer cell
Harnden, D. G. (1984) · British Journal of Cancer · doi:10.1038/bjc.1984.1 · Cited by 5
Mitotic Checkpoints, Genetic Instability, and CancerPreprint
Dobles, M., & Sorger, P. K. (2000) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2000.65.361 · Cited by 5
“Errors in DNA metabolism such as incomplete DNA repair and inappropriate recombination are known to contribute to human cancer (de Klein et al. 1982; Leach et al. 1993; Parsons et al. 1993).”
BackgroundRestriction fragment length polymorphism caused by a deletion within the human c-abl gene (ABL).
Xu, D. Q., & Galibert, F. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.10.3447 · Cited by 5
Translocation of c-abl oncogene and PDGFB (c-sis) gene in a case of CML with 46, XY, t(22;22)
Gradl, G., Tesch, H., Schwieder, G., Wagner, T., & Fonatsch, C. (1989) · Annals of Hematology · doi:10.1007/bf00320166 · Cited by 5
Ohyashiki, J. H., Ohyashiki, K., Shimizu, H., Miki, M., Kimura, N., Mori, S., Fujisawa, K., AKATSUKA, J., & Toyama, K. (1988) · American Journal of Hematology · doi:10.1002/ajh.2830290308 · Cited by 5
Xodo, L. E., Manzini, G., & Quadrifoglio, F. (1998) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1998.8.477 · Cited by 5
“Breakpoints occur on chromosome 9 at band q34, the locus of the abl proto-oncogene, and on chromosome 22 at band q 11, the locus of the bcr gene (De Klein et al., 1982).”
The Impact of Cytogenetics and Molecular Genetics on Diagnosis and Treatment
Freireich, E. J. (1990) · Springer eBooks · doi:10.1007/978-3-642-75484-5_6 · Cited by 5
The Role of the Immune System in Anti-Tumour Responses: Potential for Drug Therapy
Dermime, S., Barrett, J. A., & Gambacorti-Passerini, C. B. (1995) · Drugs & Aging · doi:10.2165/00002512-199507040-00002 · Cited by 5
Molecular Analysis of Chromosome Breakpoints
Groffen, J., Hermans, A., Grosveld, G. C., & Heisterkamf, N. (1989) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(08)60177-4 · Cited by 5
Self-citationKlein, G. (1986) · Springer eBooks · doi:10.1007/978-1-4612-4958-0_10 · Cited by 5
Abl kinases can function as suppressors of tumor progression and metastasis
Marchal, M. A., Moose, D. L., Varzavand, A., Jordan, N. E., Taylor, D., Tanas, M. R., Brown, J. A., Henry, M. D., & Stipp, C. S. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1241056 · Cited by 4
“BCR-ABL is localized to the Philadelphia chromosome, which is generated by the reciprocal chromosomal translocation t(9;22)(q34;q11) (7), and is the major oncogenic driver in Philadelphia-positive (Ph+) leukemia cells.”
BackgroundTranslating the Genome into individualized therapeutics
Lavedan, C. N., Birznieks, G., Dressman, M. A., McCullough, K. Z., Paczkowski, R., Torres, R., Wolfgang, C. D., & Polymeropoulos, M. H. (2004) · Drug Development Research · doi:10.1002/ddr.10390 · Cited by 4
The Paradigm of Targeting an Oncogenic Tyrosine Kinase: Lesson from BCR-ABL
Bracco, E., Ali, M. S., Magnati, S., & Saglio, G. N. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.97528 · Cited by 4
Kantarjian, H. M., & Cortes, J. E. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00098-0 · Cited by 4
Yang, L., Qin, Y., Jiang, G., Feng, W., & Yuan, Y. (2022) · Medical Oncology · doi:10.1007/s12032-022-01821-w · Cited by 4
Rajcan‐Separovic, E., Bence‐Bruckler, I., Wells, P. S., & Wang, H. (1999) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(99)00047-3 · Cited by 4
Nanocolonies and diagnostics of oncological diseases associated with chromosomal translocations
Chetverina, Е. V., & Chetverin, A. B. (2010) · Biochemistry (Moscow) · doi:10.1134/s0006297910130109 · Cited by 4
Myelodysplastic syndrome with Philadelphia-like chromosome without bcr rearrangement
Ohyashiki, J. H., Ohyashiki, K., Fujieda, H., Iwabuchi, H., Enomoto, Y., Watanabe, Y., & Toyama, K. (1988) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(88)90236-1 · Cited by 4
Radha, S., & Marimuthu, K. M. (2003) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/s1383-5718(03)00111-6 · Cited by 4
Molecular Monitoring and Treatment of Chronic Myeloid Leukemia (CML)
Singh, Z. N., & Medlin, S. C. (2012) · Journal of Clinical & Experimental Pathology · doi:10.4172/2161-0681.1000113 · Cited by 4
“Molecularly, this translocation fuses the 5’ end of the BCR gene on chromosome 22 with 3’ end of the ABL1 gene on chromosome 9 and gives rise to the chimeric BCR-ABL gene [3].”
BackgroundMolecular Genetics of Lung and Pleural Neoplasms
Cagle, P. T., Jagirdar, J. S., & Popper, H. (2008) · Springer eBooks · doi:10.1007/978-0-387-72114-9_2 · Cited by 4
Leguay, T., & Mahon, F. (2005) · Encyclopédie médico-chirurgicale. Hématologie · doi:10.1016/s1155-1984(05)39940-7 · Cited by 4
Holden, J. J. A., Simpson, J. L., Ginsburg, A., Smith, A. J., & Hughes, P. (1986) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(86)90208-6 · Cited by 4
Biochemical, Immunological, and Molecular Markers of Hemopoietic Precursor Cells
Bonati, A. (1991) · Blood cell biochemistry · doi:10.1007/978-1-4615-3796-0_1 · Cited by 4
Metadata
- Authors
- Klein, A. D., Kessel, A. G. V., Grosveld, G., Bartram, C. R., Hagemeijer, A., Bootsma, D., Spurr, N. K., Heisterkamp, N., Groffen, J., & Stephenson, J. R.
- Affiliations
- Erasmus University Rotterdam (NL)
- National Cancer Institute (US)
- Venue
- Nature
- Published
- 1982-12
- Volume
- 300
- Issue
- 5894
- Pages
- 765-767
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2060833726
- Cited by
- 1,378
- References
- 27
- Citations by year
- 2026: 8 · 2025: 6 · 2024: 17 · 2023: 12 · 2022: 25 · 2021: 17 · 2020: 18 · 2019: 15 · 2018: 23 · 2017: 28 · 2016: 24 · 2015: 33 · 2014: 16 · 2013: 26 · 2012: 33
- FWCI
- 50.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Chronic Myeloid Leukemia Treatments
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Keywords
- Philadelphia chromosome, chromosome 9, chromosome 22, reciprocal translocation, cellular oncogenes, somatic cell hybrids
- MeSH terms
- Chromosomes, Human, 21-22 and Y, Chromosomes, Human, 6-12 and X, DNA, Neoplasm, Gene Expression Regulation, Humans, Leukemia, Myeloid, Oncogenes, Translocation, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.